Asahi Kasei Corporation (AHKSF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
As of 01:16PM EDT. Market open.
| Previous Close | 7.10 |
| Open | 7.15 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 7.15 - 7.15 |
| 52 Week Range | 6.00 - 7.66 |
| Volume | |
| Avg. Volume | 734 |
| Market Cap | 9.911B |
| Beta (5Y Monthly) | 0.75 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.24 (3.35%) |
| Ex-Dividend Date | Mar 28, 2024 |
| 1y Target Est | N/A |
- Business Wire
Asahi Kasei Bioprocess to Unveil THESYS™ ACS ERGO Synthesis Column at TIDES USA
TOKYO & NEW YORK & DÜSSELDORF, Germany, May 02, 2024--Asahi Kasei Bioprocess' (AKB) THESYS™ ACS ERGO synthesis column will be on display and demonstrated at Booth 213 at TIDES USA 2024.
- Business Wire
Asahi Kasei to Construct a Lithium-ion Battery Separator Plant in Canada
TOKYO & NEW YORK & DÜSSELDORF, Germany, April 25, 2024--Asahi Kasei plans to construct an integrated plant in Ontario, Canada for base film manufacturing and coating of Hipore™ wet-process LIB separator.
- Business Wire
Asahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide Therapeutics Development
TOKYO & NEW YORK & DÜSSELDORF, Germany, April 11, 2024--Asahi Kasei Bioprocess (AKB) and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics.
© 2024 Yahoo. All rights reserved.